LEN
52
2
NWS
79
-4
HPE
70
2
UHS
54
-4
MS
80
-3
DE
36
-2
SYY
47
-2
LNC
45
-4
ETR
68
-3
DRI
56
2
UNH
63
-2
CI
52
-7
STZ
58
3
DOV
73
4
ABT
57
-5
EMN
50
-2
EMC
53
-3
CNP
50
-2
TRV
56
-2
BK
72
-2
LEN
52
2
NWS
79
-4
HPE
70
2
UHS
54
-4
MS
80
-3
DE
36
-2
SYY
47
-2
LNC
45
-4
ETR
68
-3
DRI
56
2
UNH
63
-2
CI
52
-7
STZ
58
3
DOV
73
4
ABT
57
-5
EMN
50
-2
EMC
53
-3
CNP
50
-2
TRV
56
-2
BK
72
-2
Financhill
Back

Sarepta Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
31

SRPT
Sarepta Therapeutics

Last Price:
109.05
Seasonality Move:
19.2%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
65.58
Seasonality Move:
13.04%
Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $112.48. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.66. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $112.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.6 Sell
Relative Strength Index (14 RSI): 30.53 Sell
Chaikin Money Flow: -576241 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.6 - 129.58) Sell
Bollinger Bands (100): (122.9 - 146.68) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.6 Sell
Relative Strength Index (14 RSI): 37.31 Sell
Chaikin Money Flow: 458693 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.62 - 70.38) Sell
Bollinger Bands (100): (70.1 - 87.88) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 120.33 Sell
20-day SMA: 125.09 Sell
50-day SMA: 124.91 Sell
200-day SMA: 130.53 Sell
8-day EMA: 119.07 Sell
20-day EMA: 122.65 Sell
50-day EMA: 126.04 Sell
200-day EMA: 127.3 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.42 Buy
20-day SMA: 68.09 Sell
50-day SMA: 71.64 Sell
200-day SMA: 81.94 Sell
8-day EMA: 66.7 Sell
20-day EMA: 67.88 Sell
50-day EMA: 71.83 Sell
200-day EMA: 80.55 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):